RecruitingPhase 3NCT03933631

Pilocarpine Use After Kahook Goniotomy

A Prospective Randomized Control Trial of Pilocarpine Use After Combined Cataract/Kahook Dual Blade Surgery


Sponsor

Montefiore Medical Center

Enrollment

142 participants

Start Date

May 1, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + Kahook Dual Blade (KDB) surgery.


Eligibility

Min Age: 30 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying whether using pilocarpine eye drops after Kahook Dual Blade goniotomy — a minimally invasive glaucoma procedure done during cataract surgery — helps lower eye pressure more effectively than surgery alone. **You may be eligible if...** - You have ocular hypertension (high eye pressure) or open-angle glaucoma - You are scheduled for combined cataract surgery with Kahook Dual Blade goniotomy at Montefiore Medical Center **You may NOT be eligible if...** - You have had any previous eye surgeries, including laser procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPilocarpine

pilocarpine hydrochloride ophthalmic solution 2% (20 mg/mL)

DRUGPrednisolone

Prednisolone acetate ophthalmic suspension 1%

DRUGOfloxacin

Ofloxacin Drops


Locations(2)

Montefiore Wakefield Campus

The Bronx, New York, United States

Montefiore Medical Center

The Bronx, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03933631


Related Trials